APOB and familial hyperaldosteronism: The major determinants in that system are LDLR, accounting for 80–85% of FH cases, apoB100, causing 5–10% of the cases, PCSK9 2% of the cases and LDL receptor adaptor protein 1 (LDLRAP1) accounting for less than 1% of the cases [85].